Institute of Reproduction and Stem Cell Engineering, Central South University, 110 Xiangya Road, Changsha 410078, China.
Mol Biol Rep. 2011 Jun;38(5):3061-5. doi: 10.1007/s11033-010-9973-9. Epub 2010 Feb 3.
MicroRNAs (miRNAs) are 19- to 25-nt fragments cleaved from 70- to 100-nt hairpin precursors. These molecules participate in essential biological processes. It was estimated that 30% of all protein-coding genes are miRNA targets. Thousands of miRNAs have already been identified in plants and animals, but little is known about their biological roles. MicroRNA375 (miR375) is highly expressed in pancreatic islets of humans and mice and regulates insulin secretion in isolated pancreatic cells. To improve our understanding of the biological roles of miR375, we constructed the plasmid pAAV-miR375 and transfected it into mouse Nit-1 cells. Real-time PCR and Northern blot analysis showed that the Nit-1 cells transfected with pAAV-miR375 over-expressed the mature miR375 compared with Nit-1 cells transfected with control plasmid or untransfected cells. The expression of myotrophin (Mtpn) decreased and insulin secretion was reduced in Nit-1 cells transfected with pAAV-miR375. In this study, we successfully established an over-expression system for miR375 and a technique to study the biological function of miRNAs by over-expression. We verified that miR375 reduced glucose-induced insulin secretion by down-regulating the expression of Mtpn in Nit-1 cells in vitro, suggesting that miR375 has potential therapeutic applications in type II diabetes.
微小 RNA(miRNAs)是从 70 到 100 个核苷酸发夹前体中切割出的 19 到 25 个核苷酸片段。这些分子参与重要的生物过程。据估计,所有蛋白质编码基因的 30%都是 miRNA 的靶标。已经在植物和动物中鉴定出数千种 miRNA,但对它们的生物学作用知之甚少。miR375 在人和小鼠的胰岛中高度表达,并调节分离的胰腺细胞中的胰岛素分泌。为了提高对 miR375 生物学作用的认识,我们构建了质粒 pAAV-miR375 并将其转染到小鼠 Nit-1 细胞中。实时 PCR 和 Northern blot 分析显示,与转染对照质粒或未转染细胞的 Nit-1 细胞相比,转染 pAAV-miR375 的 Nit-1 细胞过表达成熟的 miR375。转染 pAAV-miR375 的 Nit-1 细胞中肌生成素(Mtpn)的表达减少,胰岛素分泌减少。在这项研究中,我们成功建立了 miR375 的过表达系统,并建立了通过过表达研究 miRNA 生物学功能的技术。我们验证了 miR375 通过下调 Nit-1 细胞中 Mtpn 的表达来减少葡萄糖诱导的胰岛素分泌,表明 miR375在 II 型糖尿病中具有潜在的治疗应用。